Intellectual Property News & Topics - Secerna LLP

REXULTI

A to Z: Drugs in Highlight: R is for REXULTI®

News A to Z Feature 03/04/2025

This series continues to explore the fascinating world of pharmaceuticals. Next up is R is for REXULTI® (from Otsuka Pharmaceutical), also sold under the brand name RXULTI®, It is an antipsychotic medicine used to treat schizophrenia in adults. It is also used as an adjunctive therapy for the treatment of major depressive disorder.

Read more

Secerna Header Images (5)

Events, News 21/07/2023

Join us at the Medical Technology Ireland Expo & Conference

Shep Mcallister J1j3cimjmge Unsplash

Industry news, News 17/07/2023

The Centre Court role of intellectual property at Wimbledon

European Patent Office Building

News 14/07/2023

New Referral to Enlarged Board of Appeal at the EPO regarding level of disclosure of prior art complex products

Taster Day July 2023

Events, News 12/07/2023

Secerna's Taster Day Unveils the Excitement of a Career in Patent Law

JP3 2544

Industry news, News 05/07/2023

Secerna LLP Receives Ongoing Recognition as a Leading Firm by IAM 1000

Antibodies_Testing_Image

News 04/07/2023

Assessing Inventive Step of Antibodies at the European Patent Office

B012853

Team news, Careers 20/06/2023

Grace Holliday in profile

Dermot GB2 1498 Nov 22

Events 18/06/2023

Secerna to attend Dublin IP and R&D Summit

Secerna Header Images (3)

Events, News 12/06/2023

Secerna LLP to attend BioFocus 2023 in Newcastle

13 14 15 16 17 18 19 20 21 22 23